Zinab Alzufari, Rosul Makkiyah, Aisha Alowais, Aisha Almazrouei, Abdul Kareem A Abu Ali, Abdulaziz Alnaqbi, Jibran Sualeh Muhammad
Prevalence of Imposter Syndrome and Its Risk Factors Among University of Sharjah Medical Students
Cureus
deprescribing plannedsupervised method dose reduction cessation medications might harmful longer beneficial though benefits deprescribing debatable improving clinical outcomes associated decreased number potentially inappropriate medications may potentially reduce risk adverse events among hospitalized older adults unclear evidence deprescribing population study aimed examine timetofirst unplanned healthcare utilization included 90day emergency department ed visits hospital readmission associated predictors deprescribing intervention secondary data analysis clinical trial shedmeds nct02979353 performed cox regression used compare timetofirst 90day ed visitreadmissiondeath hospital discharge intervention control groups additionally performed exploratory analysis predictors comorbidities functional health status drug burden index dbi hospital length stay health literacy food insecurity financial burden associated timetofirst 90day ed visitreadmissiondeath hazard first 90day ed visitsreadmissionsdeath 15 lower intervention versus control group 95 ci 061119 p 0352 respectively however difference statistically significant every additional number comorbidities hazard ratio hr 112 95 ci 104121 additional day hospital length stay hr 104 95 ci 101107 significantly associated higher hazard 90day ed visitreadmissiondeath intervention group whereas unit increase prehospital dbi score hr 108 hr 116 respectively significantly associated higher hazard 90day ed visitreadmissiondeath control group intervention control groups comparable timetofirst 90day ed visitreadmissiondeath deprescribing intervention finding suggests deprescribing result higher risk ed visitreadmissiondeath 90day period following hospital discharge